| Study name |
Rationale and design of a cluster‐randomised multifaceted intervention trial to improve stroke care quality in China: the GOLDEN BRIDGE‐Acute Ischemic Stroke |
| Methods |
Cluster‐RCT |
| Participants |
40 hospitals in China |
| Interventions |
Multi‐faceted quality improvement intervention (experimental group) or routine standard of care (control group) |
| Outcomes |
Measure of adherence to evidence‐based performance measures: in‐hospital death; new vascular event; disability; all‐cause death at 3, 6, and 12 months after initial symptom onset |
| Starting date |
‐ |
| Contact information |
Wang Yilong, Tiantan Clinical Trial and Research Center for Stroke, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China |
| Notes |
ClinicalTrials.gov/NCT02212912
|
